10 Best Healthcare PR Agencies (2026)
Healthcare PR is three separate businesses sharing one search term, and they are separated by how much regulation applies to what you say.
Regulated life sciences: Syneos Health, Real Chemistry, Sam Brown, JPA Health. Promotional claims are governed and everything passes medical and legal review.
Health technology: SHIFT, Matter, RH Strategic. Closer to ordinary B2B technology PR, as long as you make no clinical claims.
Patient acquisition: Intrepy. Performance marketing for private practices, not media relations at all.
Nobody publishes a price, and the scale range is the widest of any vertical: from 26,000+ employees to a single-address independent, ranking for the same term.
Healthcare has the broadest definition problem of any vertical we have looked at. A drug launch, a hospital software product and an orthopedic practice wanting more appointments are all healthcare marketing, and the agencies that do them well have almost nothing in common.
This list sorts 10 agencies by which healthcare they actually serve, and records what pricing each publishes.
Disclosure: MentionAgent is our own product. It is outreach software, not a PR agency, so it is not ranked among the 10 below. It appears at the end as the option for coverage and links without a retainer.
We checked the US top 10 for healthcare pr agency on 26 August 2026 and opened every result.
Three of the nine ranking results were not agencies, and one of those was ranking first: O'Dwyer's directory, PRovoke Media's global list, and a Reddit thread.
Not one of the ten publishes a price. Across the verticals we have measured, healthcare is the only one where the figure is zero.
The scale range is extraordinary. Syneos Health reports over 26,000 employees, 480+ MDs and 750+ PhDs. Sam Brown is an independent working from one address in Wayne, Pennsylvania. Both rank on page one for the same query.
Full method and the wider 19-term dataset: PR agency pricing study.
Regulation is the dividing line, not size
Most healthcare agency rankings sort by revenue or awards. The distinction that actually changes what you get is how constrained your claims are.
If you sell a regulated product, meaning a drug, a biologic or a medical device, what you may say about it is governed. Materials pass through medical, legal and regulatory review. The difference between disease awareness and product promotion is a real line with consequences on the wrong side of it. An agency without that experience will produce work that reads well and never clears review, and you will pay for both the work and the delay.
If you sell health technology that makes no clinical claim, a scheduling platform or a revenue cycle tool, you are closer to ordinary B2B technology PR. Your buyers are administrators and IT leaders, your press is trade technology media, and a general technology agency with a healthcare practice will serve you.
If you are a provider wanting more patients, this is not PR at all. It is local search, paid acquisition and reputation management, measured in appointments. Agencies that do it well, like Intrepy, describe it in exactly those terms rather than dressing it as media relations.
Getting this wrong is expensive in both directions. A pharma-grade agency running your scheduling software launch is charging you for regulatory rigour you do not need. A technology agency running your device launch will get your materials rejected.
How to judge a healthcare PR agency
1. Ask how they work with medical, legal and regulatory review. For regulated products this is the single most predictive question. You want to hear a process, timelines and how they handle a rejection, not an assurance that they are familiar with it.
2. Check whether the reference clients match your regulatory position. A roster full of health tech means little if you are launching a therapy, and the reverse is equally true. Ask specifically for clients at your stage and under your constraints.
3. Work out whether you will use the network. Large organisations bring medical affairs, data, and commercial capability alongside communications. That is genuinely valuable for a global launch and pure overhead for a Series A health tech company. You pay for the infrastructure either way.
4. Separate coverage from links. A placement in a clinical or trade publication builds credibility with prescribers, payers or administrators. A link from a site your buyers read builds search visibility. Different purchases. Our digital PR guide covers where they meet, and relevant backlinks explains why prestige and link value diverge.
Quick comparison
| Agency | Which healthcare | Scale and base | Published pricing |
|---|---|---|---|
| 1. Syneos Health | Regulated life sciences | 26,000+ employees, global | None |
| 2. Real Chemistry | Regulated life sciences | Global, 25 years | None |
| 3. Sam Brown | Biotech, device, pharma | Independent, Wayne PA | None |
| 4. JPA Health | Life sciences and federal | Not stated | None |
| 5. SHIFT Communications | Health tech | 4 US offices, group owned | None |
| 6. Matter Communications | Health tech and consumer | 6 US offices | None |
| 7. RH Strategic | Health tech, public health | Seattle and Washington DC | None |
| 8. FINN Partners | Health within a network | US, EMEA, APAC | None |
| 9. Intrepy | Patient acquisition | Georgia | None |
| 10. Edelman | Health practice, global | Global | Could not check |
Pricing is what each agency published on its own site on 26 August 2026. "None" means no number is publicly stated, not that it is cheap. Edelman's site returned a 403 to our checks, so it is recorded as could not check rather than as zero.
1. Syneos Health: not a PR agency, and that is the point
Which healthcare: Regulated biopharmaceutical, end to end.
Pricing: Not published.
Syneos Health describes itself as a fully integrated biopharmaceutical solutions organisation, spanning clinical development, medical affairs, commercial delivery and consulting. It reports over 26,000 employees, more than 480 MDs and more than 750 PhDs, and states involvement in the majority of recently approved novel drugs at the FDA and EMA. Communications is one capability inside a business that also runs trials.
Best for: Companies taking a therapy from trial to market who want clinical, medical affairs and commercial communications joined rather than coordinated across vendors.
Trade-offs: This is not a PR retainer, it is a services relationship with an organisation of that scale. If all you need is media relations, almost everything that makes Syneos valuable is irrelevant to you.
2. Real Chemistry: science communications with data attached
Which healthcare: Regulated life sciences, medical affairs, oncology.
Pricing: Not published.
Real Chemistry describes its work as connecting science with storytellers so that medicines and therapies reach their market potential, across healthcare marketing, medical affairs, data analytics and science communication. It cites 25 years of operating history and has been explicit about building AI capability into its offer, which is further than most healthcare agencies have gone publicly.
Best for: Life sciences companies who want communications informed by their own data, particularly in oncology and specialty therapeutics.
Trade-offs: Large integrated firms carry large minimums and layered process. Ask what the account team looks like day to day rather than what the organisation can theoretically do.
3. Sam Brown: independent, and built for the development cycle
Which healthcare: Biotechnology, medical device and pharmaceutical companies at all phases of development and commercialisation.
Pricing: Not published.
Sam Brown is a full-service independent healthcare communications agency working from Wayne, Pennsylvania, covering public relations, corporate communications, financial communications, strategic planning and brand management. The financial communications capability alongside product PR matters for a biotech, where investor and clinical audiences move on the same news.
Best for: Clinical-stage biotechs where trial data, financing and product narrative all need handling by people who understand each other.
Trade-offs: An independent of this size cannot staff a simultaneous multi-country launch the way a network can. If you are approaching global commercialisation, ask directly how they scale.
4. JPA Health: life sciences, public health and federal in one place
Which healthcare: Life sciences, public health, health tech and services, and federal government.
Pricing: Not published.
JPA Health offers marketing, medical communications, public relations and advocacy across four named sectors. The unusual one is federal government, sitting beside life sciences and public health. That combination points at work where a health message has to reach clinicians, the public and policymakers at the same time.
Best for: Organisations whose communications have a policy or public health dimension as well as a commercial one, including anyone with federal contracts.
Trade-offs: Four sectors with genuinely different audiences means asking which of them your account team actually works in. Advocacy and product PR are different crafts.
5. SHIFT Communications: health tech inside a performance frame
Which healthcare: Health technology, within a broad technology and consumer practice.
Pricing: Not published.
SHIFT is part of Avenir Global and Padilla, running from Boston, Chicago, New York and San Francisco. It frames its work as performance communications across earned, paid, owned and shared, including AI search optimisation. Its healthcare page sits alongside technology, fintech and consumer, which tells you the shape of the healthcare work: technology companies serving health, not therapies.
Best for: Digital health and health IT companies who want PR reported in the same frame as paid media.
Trade-offs: This is not the agency for a regulated product launch. Group ownership also brings group-level minimums and more process.
6. Matter Communications: health tech with consumer reach attached
Which healthcare: Healthcare as one of five verticals, alongside B2B technology, consumer, cybersecurity and professional services.
Pricing: Not published.
Matter works from Boston, Newburyport, Providence, Rochester, Dallas and Denver as a B2B tech and consumer PR agency supported by marketing and creative. The consumer practice sitting beside healthcare is the useful part: health stories cross into mainstream press more often than most B2B categories, and an agency that can work both sides is better placed when yours does.
Best for: Health technology companies whose story sometimes needs consumer or mainstream press, particularly anything patient-facing.
Trade-offs: Healthcare is one of five verticals rather than the whole firm, and there is no regulated life sciences depth here. Ask how many of the account team work in health full time.
7. RH Strategic: public health and public affairs together
Which healthcare: Healthcare and public sector, alongside technology, higher education and sustainability.
Pricing: Not published.
RH Strategic runs from Seattle and Washington DC across strategy and insights, content and creative, public relations, public affairs, and digital and analytics. Running PR and public affairs as siblings is the reason it appears on healthcare lists: health communications frequently needs the same message to work with regulators, legislators and journalists at once.
Best for: Health organisations with a policy, advocacy or public sector dimension, including public health programmes.
Trade-offs: If you have no policy exposure, the capability that distinguishes this agency does not apply, and a dedicated health shop will know your clinical press better.
8. FINN Partners: health as one sector of nineteen
Which healthcare: Health within a network covering more than 19 industries.
Pricing: Not published.
FINN Partners works with more than 400 brands and organisations, with offices across the US, EMEA including France, Germany, Ireland, Israel and the UK, and APAC including Greater China, India, Malaysia, Myanmar, the Philippines, Singapore and Thailand. Health sits alongside financial services, travel, consumer, energy and technology.
Best for: Health organisations who also need non-health reach, or who need the same story to land in several countries at once.
Trade-offs: Health is one of nineteen sectors. Breadth is the product, so ask how many of the account team work on health full time and in which markets.
9. Intrepy: the one that is not doing PR
Which healthcare: Private medical practices and healthcare organisations, from solo providers to private equity backed groups.
Pricing: Not published. Offers a free practice assessment.
Intrepy is a healthcare marketing agency in Georgia working exclusively with providers, across medical SEO, website design, paid advertising, social media and reporting. Specialties include orthopedics, medical spas, dermatology, ophthalmology, plastic surgery and home health. It describes its job as increasing revenue and generating patient appointments, which is a refreshingly plain statement of what provider marketing is for.
Best for: Practices and provider groups who want more patients and should be measuring appointments rather than coverage.
Trade-offs: This is performance marketing, not media relations. If you need to communicate about a product, a trial or a policy position, this is the wrong category entirely.
10. Edelman: the global network, unverifiable from outside
Which healthcare: A dedicated Health practice within a global communications firm.
Pricing: Could not check. Edelman's site returned a 403 to our automated checks, so we are recording that rather than inferring anything from it.
Edelman's Health page ranks second in the US for this search, which places it firmly on any shortlist assembled from search results. We include it for that reason and decline to characterise its offer in detail, because we could not read the page ourselves and would rather say so than repeat what other lists claim.
Best for: Multi-market health communications programmes at a scale where a global network is genuinely used.
Trade-offs: Global networks carry global minimums. As with any large firm, the question to ask is who staffs your account day to day, and whether that is contractual.
Also worth knowing: three of the results ranking for this search are not agencies, and one of them ranks first. O'Dwyer's publishes a healthcare PR firms ranking and directory, and PRovoke Media publishes a list of the best healthcare agencies globally. Both are useful cross-checks precisely because they are not competing for your business, and both are directories rather than recommendations.
What the pricing silence tells you
Across every vertical in our pricing study, most agencies publish nothing. Healthcare is the only one where the count reached zero.
Regulated work costs more, and nobody will say by how much. Medical, legal and regulatory review adds hours to every asset, and someone pays for those hours. When you compare a health tech quote against a life sciences quote, you are not comparing the same product.
Quote-only pricing is priced to your size. When scoping happens on a call, the number reflects what your organisation appears able to pay. Stating a budget up front anchors that conversation.
The scale range makes benchmarks meaningless here. An organisation of 26,000 people and a single-office independent both rank for this term. There is no useful average across that spread, so gather two or three quotes from agencies in your own category rather than from the search results as a whole. Our digital PR costs guide has the wider picture.
If you would rather not hire an agency
Everything above is a retainer for a team working on your behalf. For a therapy launch, a trial readout or a regulatory question, that is the right purchase and software is not a substitute. It is an expensive purchase when what you want is steady coverage and links from the health technology blogs and newsletters your buyers already read.
MentionAgent is $99/mo flat. The agent finds relevant posts in your niche, looks up the author's verified email, writes a pitch tied to the specific article, and sends it once you approve it in Telegram. Follow-ups run until someone replies. No credits, no per-contact fees, no minimum term, so the bill does not move when the volume does.
One caveat specific to this sector: if your claims are regulated, every outbound message is a regulated communication too, and it needs the same review as anything else you publish. MentionAgent shows you each pitch before it sends, which makes that review possible, but the responsibility stays with you. We wrote the honest comparison in AI link building vs hiring an agency, including where the agency is clearly the better answer.
How to pick
Decision tree
- Taking a therapy from trial to market? → Syneos Health.
- Life sciences comms informed by your own data? → Real Chemistry.
- Clinical-stage biotech with investor and trial news together? → Sam Brown.
- Policy, public health or federal dimension? → JPA Health or RH Strategic.
- Digital health, reported alongside paid media? → SHIFT Communications.
- Patient-facing health tech that crosses into consumer press? → Matter Communications.
- Same story needed in several countries? → FINN Partners.
- A practice wanting more appointments? → Intrepy, and measure appointments.
- Global programme at network scale? → Edelman.
- Want coverage and links on a flat budget, approving every pitch? → MentionAgent.
Coverage without a network retainer
MentionAgent finds the blogs your buyers read, looks up the contacts, writes the pitches, sends them and follows up. $99/mo flat, whatever the volume. No credits, no minimum term.
Start Getting Mentioned On AutopilotFrequently asked questions
What is the best healthcare PR agency in 2026?
It depends which healthcare you mean. Syneos Health, Real Chemistry, Sam Brown and JPA Health work in regulated life sciences. SHIFT, Matter and RH Strategic handle health technology, closer to ordinary B2B tech PR. Intrepy does patient acquisition for private practices, which is performance marketing. Three different businesses sharing one search term.
How much does a healthcare PR agency cost?
None of the ten publish a figure, making healthcare the least transparent vertical we have measured. The scale range is also the widest: Syneos reports 26,000+ employees while Sam Brown works from a single Pennsylvania address, and both rank for the same query. Gather quotes from agencies in your own category. See digital PR costs.
Do healthcare PR agencies need regulatory knowledge?
For pharmaceutical, biotech and device work it is the main thing you are buying. Claims about regulated products are constrained, materials pass medical, legal and regulatory review, and the line between disease awareness and product promotion has consequences. For health technology making no clinical claims, the constraint is far lighter.
Is a big healthcare network better than a boutique?
It depends whether you need scale or attention. A network staffs a global launch and brings medical affairs and commercial capability alongside communications. A boutique gives you senior people on the account rather than in the pitch. The test is whether your programme is large enough that the infrastructure gets used, because you pay for it either way.
Who ranks healthcare PR agencies?
O'Dwyer's publishes a healthcare PR firms ranking and directory, and PRovoke Media publishes a list of the best healthcare agencies globally. Both rank highly for this search, and neither is competing for your business, which makes them useful cross-checks. They are directories rather than recommendations for your situation.